This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs) for therapeutic drugs. Its structure, featuring a bromo-fluoro-phenyl group, makes it a valuable building block in medicinal chemistry, especially for compounds targeting neurological disorders or acting as enzyme inhibitors. The ester group allows for further chemical modifications, enabling the creation of more complex molecules. Additionally, its chiral nature is significant in producing enantiomerically pure drugs, which is crucial for ensuring efficacy and reducing side effects in pharmaceutical applications.